Drug intelligence / Profile preview

feiyan qinghua decoction

Development stage
Phase 1
Lead developer
Shanghai University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Feiyan Qinghua Decoction (FYQHD) is a traditional Chinese medicine formula derived from the classical Ma Xing Shi Gan decoction, originally documented in Zhang Zhong Jing’s "Treatise on Exogenous Febrile Disease" during the Han Dynasty. FYQHD consists of nine herbal ingredients and has been used clinically for decades to treat pneumonia and infectious diseases such as sepsis and influenza. Mechanistically, FYQHD exerts its effects by inhibiting hyperinflammation—specifically through suppression of the HMGB1/RAGE signaling pathway and PI3K/AKT/mTOR/4E-BP1 axis—thereby reducing pro-inflammatory cytokine production (e.g., TNF-α, IL-6, MCP-1). It also enhances immune defense by promoting macrophage phagocytosis via upregulation of receptors like CD169 and SR-A1. In models of influenza infection, FYQHD modulates gut microbiota composition to increase short-chain fatty acid (SCFA) production (notably acetate), which boosts type I interferon responses and restores intestinal barrier integrity. These combined actions result in reduced pathogen load, improved survival rates in sepsis models, attenuation of lung injury from viral infections, and overall enhanced host antiviral immunity[1][2][3].

Other names
Fei-Yan-Qing-Hua decoctionFYQHD
02

Targets

SIGLEC1 (Siglec-1)IL-6 (Interleukin 6)SRA1 (Steroid receptor RNA activator 1)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on feiyan qinghua decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on feiyan qinghua decoction.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call